PHARMACEURICAL FORMULATION HAVING ANTICOAGULATIVE AND ANTIAGGREGATORY ACTION AND METHOD OF PRODUCTION

FIELD: medicine. ^ SUBSTANCE: offered pharmaceutical formulation with anticoagulative and antiaggregatory action contains sodium heparin as reactant and carbomers 940 or 980, trisamine, lavender oil, neroli oil and water as adjuvants taken in specific proportions. Pharmaceutical formulation has gel...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: BEZUGLAJA ELENA PETROVNA, JURCHENKO NIKOLAJ IVANOVICH, EMSHANOVA SVETLANA VITAL'EVNA, VOLOVIK NATAL'JA VALER'EVNA, ZUEV ANATOLIJ PETROVICH, LJAPUNOV NIKOLAJ ALEKSANDROVICH, LOMAKINA VALENTINA DMITRIEVNA
Format: Patent
Sprache:eng ; rus
Schlagworte:
Online-Zugang:Volltext bestellen
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:FIELD: medicine. ^ SUBSTANCE: offered pharmaceutical formulation with anticoagulative and antiaggregatory action contains sodium heparin as reactant and carbomers 940 or 980, trisamine, lavender oil, neroli oil and water as adjuvants taken in specific proportions. Pharmaceutical formulation has gel consistency. Method of production of offered formulation includes sodium heparin aqueous solution, nypagin solution, ethanol solution of lavender and neroli oil, and trisamine sequentially added to water-dispersed carbomers. ^ EFFECT: new formulation is characterised by high pharmaceutical activity; does not have by-effects; stable for keeping; has optimal viscosity and applicable organoleptic property. ^ 4 cl, 1 tbl, 3 ex